Voloridge Investment Management, LLC Editas Medicine, Inc. Transaction History

Voloridge Investment Management, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$7.03 - $11.07 $3.61 Million - $5.69 Million	-513,983 Reduced 92.54%	41,414 $307,000
Q4 2023 Feb 14, 2024	BUY	$6.25 - $11.11 $3.47 Million - $6.17 Million	555,397 New	555,397 $5.63 Million
Q2 2023 Aug 14, 2023	BUY	$6.36 - $11.47 $1.23 Million - $2.21 Million	192,692 Added 89.91%	407,001 $3.35 Million
Q1 2023 May 15, 2023	BUY	$7.03 - $11.53 $1.51 Million - $2.47 Million	214,309 New	214,309 $1.55 Million
Q2 2022 Aug 15, 2022	SELL	$9.99 - $21.35 $2.89 Million - $6.18 Million	-289,376 Reduced 39.02%	452,140 $5.35 Million
Q1 2022 May 16, 2022	BUY	$14.08 - $27.63 $1.02 Million - $2.01 Million	72,756 Added 10.88%	741,516 $14.1 Million
Q4 2021 Feb 14, 2022	BUY	$26.55 - $40.57 $6.75 Million - $10.3 Million	254,096 Added 61.28%	668,760 $17.8 Million
Q3 2021 Nov 15, 2021	BUY	$39.27 - $72.94 $7.89 Million - $14.7 Million	200,853 Added 93.94%	414,664 $17 Million
Q2 2021 Aug 16, 2021	SELL	$31.29 - $56.64 $1.89 Million - $3.43 Million	-60,470 Reduced 22.05%	213,811 $12.1 Million
Q1 2021 May 17, 2021	SELL	$39.71 - $90.58 $5.22 Million - $11.9 Million	-131,545 Reduced 32.41%	274,281 $11.5 Million
Q4 2020 Feb 16, 2021	BUY	$27.07 - $84.35 $11 Million - $34.2 Million	405,826 New	405,826 $28.5 Million
Q1 2020 May 15, 2020	SELL	$14.88 - $32.78 $515,205 - $1.13 Million	-34,624 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$19.49 - $32.63 $674,821 - $1.13 Million	34,624 New	34,624 $1.03 Million

244

56.8M

410K

394K

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $90M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Voloridge Investment Management, LLC with notifications on news.